• 1. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 2. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 3. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 4. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 5. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles 2,4-disubstituted oxazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Oxazoles 2,4-disubstituted oxazoles

Introduction to 2-cyclobutyl-1,3-oxazole-4-carboxylic acid (CAS No. 1190314-33-0)

2-cyclobutyl-1,3-oxazole-4-carboxylic acid, identified by the Chemical Abstracts Service Number (CAS No.) 1190314-33-0, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the oxazole class, characterized by a five-membered ring containing one oxygen atom and two carbon atoms, with a cyclobutyl substituent attached to the ring. The carboxylic acid functional group at the 4-position enhances its reactivity and potential utility in synthetic chemistry and drug development.

The structural features of 2-cyclobutyl-1,3-oxazole-4-carboxylic acid make it a promising candidate for further exploration in medicinal chemistry. The cyclobutyl group introduces steric hindrance, which can influence the compound's interactions with biological targets, while the oxazole ring provides a scaffold that is commonly found in biologically active molecules. These structural elements contribute to its potential role in modulating various biological pathways.

In recent years, there has been growing interest in oxazole derivatives due to their diverse pharmacological properties. Oxazoles have been reported to exhibit antimicrobial, anti-inflammatory, and anticancer activities. The presence of the carboxylic acid moiety in 2-cyclobutyl-1,3-oxazole-4-carboxylic acid suggests that it may be a valuable intermediate in the synthesis of more complex molecules with enhanced biological activity. This compound could serve as a building block for the development of novel therapeutic agents targeting various diseases.

One of the key areas of research involving 2-cyclobutyl-1,3-oxazole-4-carboxylic acid is its potential application in the synthesis of protease inhibitors. Proteases are enzymes that play crucial roles in many biological processes, and their inhibition is often a strategy employed in drug design. The oxazole ring and the carboxylic acid group provide multiple sites for interaction with protease active sites, making this compound a promising candidate for further investigation.

Furthermore, the cyclobutyl substituent may enhance the metabolic stability of any derivatives synthesized from 2-cyclobutyl-1,3-oxazole-4-carboxylic acid, which is an important consideration in drug development. Metabolic stability is crucial for ensuring that a drug remains active in the body long enough to exert its therapeutic effect. The steric bulk introduced by the cyclobutyl group can also prevent unwanted interactions with non-target enzymes, thereby increasing the selectivity of any potential drug candidates derived from this compound.

Recent studies have also explored the use of oxazole derivatives as kinase inhibitors. Kinases are enzymes that play a key role in cell signaling pathways and are often implicated in various diseases, including cancer. The structural motif of 2-cyclobutyl-1,3-oxazole-4-carboxylic acid suggests that it may be able to interact with kinase active sites, potentially leading to the development of new anticancer agents. These studies highlight the importance of 2-cyclobutyl-1,3-oxazole-4-carboxylic acid as a versatile scaffold for drug discovery.

The synthesis of 2-cyclobutyl-1,3-oxazole-4-carboxylic acid involves multi-step organic reactions that require careful optimization to ensure high yield and purity. The introduction of the cyclobutyl group onto the oxazole ring necessitates precise control over reaction conditions to avoid unwanted side products. Advances in synthetic methodologies have made it possible to produce this compound more efficiently, which bodes well for its future applications in pharmaceutical research.

In conclusion, 2-cyclobutyl-1,3-oxazole-4-carboxylic acid (CAS No. 1190314-33-0) represents a significant area of interest in medicinal chemistry due to its unique structural features and potential biological activities. Its role as an intermediate in synthesizing novel therapeutic agents underscores its importance in drug discovery efforts. As research continues to uncover new applications for this compound, it is likely to remain a key player in the development of next-generation pharmaceuticals.

• 1247889-30-0(2-cyclopentyl-1,3-oxazole-4-carboxylic acid)
• 36190-03-1(2-propyl-1,3-oxazole-4-carboxylic acid)
• 1060816-08-1(2-tert-butyl-1,3-oxazole-4-carboxylic acid)
• 1344088-62-5(methyl 2-cyclopropyloxazole-4-carboxylate)
• 153180-21-3(2-(propan-2-yl)-1,3-oxazole-4-carboxylic acid)
• 90071-66-2(4-Oxazolecarboxylic acid, 2-(2-oxononyl)-)
• 1258458-79-5(2-(5-oxo-hexyl)-oxazole-4-carboxylic acid)
• 1247415-46-8(2-(2-METHYLCYCLOPROPYL)-1,3-OXAZOLE-4-CARBOXYLIC ACID)
• 75395-42-5(2-ethyl-1,3-oxazole-4-carboxylic acid)
• 1060816-04-7(2-cyclopropyl-1,3-oxazole-4-carboxylic acid)